Development and analysis of androgen receptor (AR) axis biomarkers of circulating tumor cells (CTCs) in Japanese metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA).

Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2017.12.006 ◽

2018 ◽

Vol 36 (4) ◽

pp. 162.e1-162.e6 ◽

Cited By ~ 8

Author(s):

Sumanta K. Pal ◽

Miaoling He ◽

Lin Chen ◽

Lixin Yang ◽

Raju Pillai ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Prostate Cancer and Prostatic Diseases ◽

10.1038/s41391-018-0043-z ◽

2018 ◽

Vol 21 (3) ◽

pp. 411-418 ◽

Cited By ~ 12

Author(s):

Manish Kohli ◽

Jian Li ◽

Meijun Du ◽

David W Hillman ◽

Scott M. Dehm ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Plasma Cell ◽

Castration Resistant ◽

Free Dna ◽

Prognostic Association

Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

10.1158/1538-7445.am2015-375 ◽

2015 ◽

Author(s):

Jaymala Patel ◽

Vipul Bhargava ◽

Miaoling He ◽

Brad Foulk ◽

Denis A. Smirnov ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Molecular Characterization ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Apostream to isolate circulating tumor cells (CTC) from castration-resistant prostate cancer patients (CRPC) that express androgen receptor variant 7 (AR-V7) associated with resistance to AR-targeting drugs.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e23025 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e23025-e23025

Author(s):

Darren W. Davis ◽

Asifa Haider ◽

Valerie Pierron ◽

Fabien Schmidlin

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Androgen receptor (AR) activation levels on circulating tumor cells (CTCs) to predict response to second-line therapy in castration-resistant prostate cancer (CRPC)

Science-Business eXchange ◽

10.1038/scibx.2012.1168 ◽

2012 ◽

Vol 5 (44) ◽

pp. 1168-1168

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Second Line ◽

Second Line Therapy ◽

Castration Resistant ◽

Line Therapy

PD32-12 LONG-TERM FOLLOW-UP OF CIRCULATING TUMOR CELLS AS PREDICTORS FOR SURVIVAL IN MEN TREATED WITH ABIRATERONE ACETATE FOR CASTRATION RESISTANT PROSTATE CANCER FOLLOWING CHEMOTHERAPY

The Journal of Urology ◽

10.1016/j.juro.2016.02.688 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Christian Meyer ◽

Petra Strölin ◽

Hans Heinzer ◽

Klaus Pantel ◽

Sabine Riethdorf ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Long Term Follow Up

615P Circulating tumor cells (CTC) gene expression and plasma androgen receptor (AR) copy number (CN) in cabazitaxel-treated metastatic castration-resistant prostate cancer (mCRPC)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1128 ◽

2021 ◽

Vol 32 ◽

pp. S654-S655

Author(s):

G. Gurioli ◽

V. Conteduca ◽

N. Brighi ◽

E. Scarpi ◽

U. Basso ◽

...

Keyword(s):

Gene Expression ◽

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Copy Number ◽

Abstract 4971: Quantitative image analysis of androgen receptor (AR) and tubulin biomarker profiles in circulating tumor cells (CTCs) from metastatic castration resistant prostate cancer (mCRPC) patients

10.1158/1538-7445.am2016-4971 ◽

2016 ◽

Author(s):

Daniel Worroll ◽

Giuseppe Galletti ◽

David M. Nanus ◽

Scott T. Tagawa ◽

Paraskevi Giannakakou

Keyword(s):

Prostate Cancer ◽

Image Analysis ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Quantitative Image Analysis ◽

Castration Resistant ◽

Quantitative Image

Abstract C9: Treatment response to abiraterone acetate (AA) in patients with castration-resistant prostate cancer (CRPC) based on circulating tumor cells (CTCs), prostate-specific antigen (PSA), and imaging

Cancer Research ◽

10.1158/1538-7445.prca2012-c9 ◽

2012 ◽

Vol 72 (4 Supplement) ◽

pp. C9-C9

Author(s):

Diletta Bianchini ◽

Alison Reid ◽

Gerhardt Attard ◽

Johann De Bono ◽

Shahneen Sandhu ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Prostate Specific Antigen ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Specific Antigen ◽

Abiraterone Acetate ◽

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

European Urology ◽

10.1016/j.eururo.2011.07.011 ◽

2011 ◽

Vol 60 (5) ◽

pp. 897-904 ◽

Cited By ~ 147

Author(s):

Daniel C. Danila ◽

Aseem Anand ◽

Clifford C. Sung ◽

Glenn Heller ◽

Margaret A. Leversha ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Predictive Biomarker ◽

Abiraterone Acetate ◽